scispace - formally typeset
B

Barbro Werelius

Researcher at Karolinska Institutet

Publications -  16
Citations -  2022

Barbro Werelius is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Breast cancer & Germline mutation. The author has an hindex of 15, co-authored 16 publications receiving 1990 citations.

Papers
More filters
Journal ArticleDOI

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer.

TL;DR: Two SNPs consistently associated with breast cancer are identified: rs3803662 is near the 5′ end of TNRC9 , a high mobility group chromatin–associated protein whose expression is implicated in breast cancer metastasis to bone.
Journal ArticleDOI

Genetic mapping of a second locus predisposing to hereditary non–polyposis colon cancer

TL;DR: Tight linkage is presented between a polymorphic marker on the short arm of chromosome 3 and the disease locus, and it is found that families with hereditary–non polyposis colon cancer also manifest signs of a general DNA replication disorder.
Journal ArticleDOI

Increased frequency of sister chromatid exchanges in cigarette smokers.

TL;DR: The present results indicate that the SCE-frequency in healthy human subjects is influenced by individual smoking habits as well and strongly suggest occupational exposure as a causative factor.
Journal Article

The role of hMLH3 in familial colorectal cancer.

TL;DR: It is demonstrated in one family that a hMLH3 mutation segregated with disease together with a missense mutation in hMSH2, which makes it hypothesize that these mutations work together in an additive manner and result in an elevated risk of colorectal tumors in the family.
Journal ArticleDOI

CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk.

TL;DR: Results do not support CDH1 as a prominent low‐penetrance cancer susceptibility gene, but indicate thatCDH1 mutations contribute to the progression of both lobular and ductal tumors.